当前位置:首页 - 行情中心 - 九洲药业(603456) - 财务分析

九洲药业

(603456)

  

流通市值:132.65亿  总市值:132.85亿
流通股本:8.98亿   总股本:8.99亿

九洲药业(603456)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润10.31亿元,每股收益1.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益853307.09万元,未分配利润289319.76万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产1085198.74万元,负债231891.65万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入5,523,418,175.434,576,609,415.433,254,642,522.091,751,242,194.31
营业总成本4,275,834,833.863,422,488,804.642,473,324,172.521,355,118,342.4
营业利润1,175,771,384.981,085,851,455.66714,949,160.5349,452,953.25
利润总额1,180,642,037.571,088,016,968.01717,732,565.52349,478,460.47
净利润1,031,371,775.69964,436,582.77621,320,792.4279,457,100.43
其他综合收益2,052,331.715,785,327.026,140,465.481,417,470.14
综合收益总额1,033,424,107.4970,221,909.79627,461,257.88280,874,570.57
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计6,314,388,178.727,020,475,1127,140,152,384.646,858,639,747.84
非流动资产合计4,537,599,177.974,274,114,190.214,195,723,557.464,096,263,848.67
资产总计10,851,987,356.6911,294,589,302.2111,335,875,942.110,954,903,596.51
流动负债合计1,656,620,008.062,217,349,374.562,734,874,587.412,396,630,530.67
非流动负债合计662,296,455.42605,084,551.71494,022,732.51423,701,322
负债合计2,318,916,463.482,822,433,926.273,228,897,319.922,820,331,852.67
归属于母公司股东权益合计8,461,133,056.228,399,568,882.888,032,464,805.228,060,888,128.4
股东权益合计8,533,070,893.218,472,155,375.948,106,978,622.188,134,571,743.84
负债和股东权益合计10,851,987,356.6911,294,589,302.2111,335,875,942.110,954,903,596.51
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计5,405,224,774.924,567,723,344.063,222,956,318.442,098,706,912.05
经营活动现金流出小计4,044,900,844.533,422,455,488.822,504,090,233.021,641,822,849.86
经营活动产生的现金流量净额1,360,323,930.391,145,267,855.24718,866,085.42456,884,062.19
投资活动现金流入小计29,744,871.591,035,611.9581,770.5581,770.5
投资活动现金流出小计1,086,548,270.82752,391,080.56535,175,431.05332,807,331.64
投资活动产生的现金流量净额-1,056,803,399.23-751,355,468.66-534,593,660.55-332,225,561.14
筹资活动现金流入小计4,603,559,971.424,153,559,971.423,651,999,971.423,174,999,971.42
筹资活动现金流出小计2,501,374,630.931,441,690,439.77555,899,017.67277,815,278.49
筹资活动产生的现金流量净额2,102,185,340.492,711,869,531.653,096,100,953.752,897,184,692.93
汇率变动对现金及现金等价物的影响7,604,699.4821,480,247.5620,778,229.19-4,082,477.78
现金及现金等价物净增加额2,413,310,571.133,127,262,165.793,301,151,607.813,017,760,716.2
期末现金及现金等价物余额3,076,069,351.93,790,020,946.563,963,910,388.583,680,519,496.97
最新报告期:2024-04-13
研究机构分析师预测每股收益(元)更新日
2023年2024年2025年
财通证券张文录1.321.561.532024-04-13
中信建投证券袁清慧,贺菊颖1.401.661.912024-04-11
开源证券余汝意1.301.531.902024-04-11
中金公司张琎,吴婉桦1.311.56--2024-04-10
国联证券郑薇1.301.601.602024-04-10
TOP↑